SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-009242
Filing Date
2023-02-14
Accepted
2023-02-14 17:15:02
Documents
1
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4742
  Complete submission text file 0001209191-23-009242.txt   6095
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1616 EASTLAKE AVENUE E. SUITE 208 SEATTLE WA 98102
Business Address
Holtzman Douglas (Reporting) CIK: 0001874371 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-40655 | Film No.: 23631578